Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
26.0%
% of FTXH's 51 holdings also in BBH
52.0%
% of BBH's 27 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus BBH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in BBH |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 4.5% | 11.3% | 4.5% |
|
AMGEN INC | 3.1% | 15.4% | 3.1% |
|
BIOGEN IDEC INC | 2.9% | 3.3% | 2.9% |
|
REGENERON PHARMACEUTICALS | 2.3% | 6.4% | 2.3% |
|
CHARLES RIVER LABORATORIES | 2.4% | 1.8% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to BBH
|
BRISTOL-MYERS SQUIBB CO | 8.8% |
|
PFIZER INC | 7.3% |
|
ABBVIE INC | 7.0% |
|
JOHNSON & JOHNSON | 6.7% |
|
MERCK & CO. INC. | 6.6% |
|
CARDINAL HEALTH INC | 4.2% |
|
UNITED THERAPEUTICS CORP | 3.8% |
|
VIATRIS, INC. | 3.8% |
|
ZOETIS INC | 3.5% |
 |
JAZZ PHARMACEUTICALS PLC | 3.5% |
FTXH Underweight Relative to BBH
|
AMGEN INC | -12.3% |
|
VERTEX PHARMACEUTICALS INC | -10.0% |
|
GILEAD SCIENCES INC | -6.8% |
 |
ARGENX SE ADR | -5.6% |
|
NATERA INC | -4.9% |
|
IQVIA HOLDINGS INC | -4.7% |
|
ILLUMINA INC | -4.2% |
|
REGENERON PHARMACEUTICALS | -4.1% |
|
ICON PLC | -3.7% |
|
ALNYLAM PHARMACEUTICALS INC | -3.1% |